An understanding of the functional potential of the entire CD8+ T-cell compartment may offer insights on future responses to remaining clinical sequalae post-cure (e.g., other infections, re-infection with new strains of HCV, vaccination efficacy, and cancer surveillance to prevent HCC and extrahepatic cancers). The gene discussed is CD8A; the disease is hepatocellular carcinoma.